According to the Legislative Budget Board (LBB), HB 330 is not expected to have a significant fiscal implication to the state. The fiscal note states that the bill would limit when certain prenatal, mental health, or other medical professionals must report a voluntary disclosure of illegal controlled-substance use during pregnancy, and would also restrict DFPS from investigating certain abuse or neglect reports when the person enrolls in and successfully completes a supervised substance abuse treatment program during pregnancy.

The main fiscal consideration identified by the LBB is not a direct cost, but a potential federal compliance issue. DFPS reported that changes to Family Code Section 261.101 could potentially conflict with federal requirements under the Comprehensive Addiction and Recovery Act. DFPS currently uses professional reporting in cases involving infants affected by prenatal substance exposure, withdrawal symptoms, or Fetal Alcohol Spectrum Disorder to help satisfy those federal requirements. Because the bill would remove the reporting requirement in certain circumstances, DFPS indicated that the agency could potentially be out of compliance with the federal act.

The LBB assumes that any costs to DFPS could be absorbed within existing resources. The fiscal note also states that no fiscal implication to units of local government is anticipated.

HB 330 does not grow the size of government in the conventional fiscal or bureaucratic sense. It does not create a new agency, office, program, fund, criminal offense, civil penalty, or rulemaking authority. The bill does not expressly create a criminal offense, increase criminal punishment, change supervision eligibility, or grant additional rulemaking authority to a state officer, department, agency, or institution. On those limited-government metrics, the bill is not an expansion of state structure.

The bill also does not appear to increase the burden on taxpayers. The LBB states that no significant fiscal implication to the state is anticipated and assumes that any costs to the Department of Family and Protective Services could be absorbed within existing resources. The fiscal note also states that no fiscal implication to units of local government is anticipated. Accordingly, taxpayer exposure is not the principal basis for opposition.

Nor does the bill meaningfully increase the regulatory burden on individuals or businesses. To the contrary, it reduces a reporting obligation for certain prenatal, mental health, or other medical professionals when a pregnant person voluntarily discloses illegal controlled-substance use during pregnancy and certain treatment and immediate-risk conditions are satisfied. The bill’s regulatory effect is deregulatory for those professionals in the narrow circumstances covered by the bill.

Texas Policy Research recommends that lawmakers vote NO on HB 330, not because the bill expands government, raises taxes, or imposes new regulatory burdens. The concern is that the bill narrows the state’s child-protection reporting and investigation framework in a category of cases involving illegal controlled-substance use during pregnancy. Under current child-welfare policy, mandatory reporting serves as the mechanism that brings possible abuse or neglect to the attention of the agency charged with independent child-safety review. HB 330 would allow a treating professional’s judgment that there is no immediate risk of harm to prevent a report from being required, provided the person is enrolled in, has recently completed, or has made reasonable efforts within 10 days to enroll in a substance abuse treatment program.

That structure places substantial weight on the treating professional’s immediate-risk determination and the person’s treatment-related efforts, rather than preserving independent DFPS review in all cases involving admitted illegal drug use during pregnancy. While encouraging treatment is a legitimate policy goal, the bill may create too broad a safe harbor by reducing mandatory reporting before DFPS has the opportunity to screen the case. A conservative lawmaker could reasonably conclude that prenatal drug exposure presents a sufficiently serious child-welfare concern that treatment participation should inform DFPS’s response, not prevent the report or investigation from occurring.

The bill also raises a concern about deterrence and moral hazard. The Committee Substitute recognizes “reasonable efforts” to enroll in treatment, including joining a waitlist, within 10 days after disclosure. That standard may be too permissive where the underlying conduct involves illegal controlled-substance use during pregnancy. Even though the bill does not bar reporting when an immediate risk exists, opponents may view the safe harbor as weakening accountability for conduct that can endanger a child before birth.

There is also an implementation risk. The LBB fiscal note reports that DFPS believes the change to Family Code Section 261.101 could potentially conflict with federal requirements under the Comprehensive Addiction and Recovery Act because DFPS uses professional reporting in cases involving infants affected by prenatal substance exposure, withdrawal symptoms, or Fetal Alcohol Spectrum Disorder to comply with federal law. Although the LBB does not estimate a high fiscal cost, the federal compliance issue reinforces the concern that the bill could create uncertainty in the child-protection system.

The bill has little direct impact on free enterprise. It does not create a new occupational license, business mandate, tax, fee, subsidy, or market restriction. It modestly reduces compliance pressure on certain medical and mental health professionals by creating a narrow exception to mandatory reporting, but the effect is limited to a specific child-welfare reporting context.

The bill does not materially affect private property rights. It does not regulate land use, authorize takings, condition property use on compliance, affect ownership interests, or expand eminent domain authority. Its property-rights impact is neutral.

The bill attempts to encourage responsibility by tying the reporting exception to enrollment in, recent completion of, or reasonable efforts to enroll in substance abuse treatment. It also bars certain DFPS investigations only if the person enrolls in supervised treatment during pregnancy and successfully completes the program. Still, the standard is relatively permissive because “reasonable efforts” may include joining a waitlist within 10 days. A stronger personal-responsibility framework would preserve mandatory reporting while allowing treatment participation and completion to affect DFPS’s response. As written, the bill may reduce accountability for illegal drug use during pregnancy before an independent child-protection review occurs.

The bill does not grow government in the usual structural or fiscal sense. It does not create a new agency, program, criminal offense, penalty, or rulemaking authority, and the LBB anticipates no significant fiscal implication to the state or local governments. However, limited government also requires government to perform core protective functions within clear statutory boundaries. The concern is that the bill restricts DFPS reporting and investigation authority in cases involving illegal controlled-substance use during pregnancy, potentially preventing independent review of child-safety concerns. DFPS also identified a possible federal-compliance issue related to reporting requirements for infants affected by prenatal substance exposure. For that reason, the bill reduces government action, but not necessarily in a way that is well-tailored to the state’s core child-protection responsibility.

The bill reduces state intervention for a pregnant person who voluntarily discloses illegal controlled-substance use to a prenatal, mental health, or other medical professional and satisfies treatment-related conditions. In that respect, it protects medical candor and reduces the likelihood that seeking care automatically triggers state action. However, the liberty benefit is limited by the child-welfare context. Because the bill narrows mandatory reporting and may prevent DFPS review in cases involving prenatal drug exposure, it raises concerns about the child’s interest in protection from harm. On balance, the bill advances the liberty of the pregnant person and treating professional but does so by weakening an existing child-protection safeguard.